To exploit hERG1 as a novel target for in vivo molecular imaging, we generated and characterized smaller size antibody fragments in the scFv format, with the aim of obtaining the proof of concept for their further use as a molecular tool for in vivo cancer imaging. The gene discussed is KCNH2; the disease is cancer.